Issue Date: June 18, 2012
New Way To Hit Alzheimer’s Target: Caspase-6 Inhibitor
An agent that inhibits the protease enzyme caspase-6 in a totally new way could help lead to a novel type of medication for Alzheimer’s disease, a condition in which caspase-6 may play a key role.
Drug researchers in academia and the pharmaceutical industry have been actively pursuing inhibitors of caspase-6 and other caspases as potential Alzheimer’s medications for several years. But inhibitors against caspases have been found to cause serious side effects, and none has . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society